middle.news
How Will Firebrick Pharma Turn $1.26M Loss Into Growth with Nasodine Throat Spray?
1:12pm on Tuesday 24th of February, 2026 AEDT
•
Healthcare
Read Story
How Will Firebrick Pharma Turn $1.26M Loss Into Growth with Nasodine Throat Spray?
1:12pm on Tuesday 24th of February, 2026 AEDT
Key Points
Half-year net loss improved by 12.7% to $1.26 million
Revenue down 67.8% due to timing of large sales but cash revenue up 42%
Nasodine Throat Spray launched in Singapore and Fiji export markets
Philippines FDA review underway for Nasodine Nasal Spray approval
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
FIREBRICK PHARMA (ASX:FRE)
OPEN ARTICLE